Hunter Immunology
2003
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Probiomics
Primary Office
- Avalon Parade 61
- Sydney, New South Wales 2107
- Australia
Hunter Immunology Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Hunter Immunology‘s full profile, request access.
Request full access to PitchBook